Authors
Latest:
There Are Two Significant Advantages to the Decriminalization of PsychedelicsTo build a brighter, healthier, and more equitable future for all US citizens, there is an indisputable need to decriminalize psychedelic medicines.
Latest:
Advancing Treatment Selection in CLL ManagementTreatment options are distinct in their mechanisms, safety profiles, and implications for patients’ quality of life.
Latest:
Telehealth & AI: Enhancing Accessibility and Continuity in Patient CareThe transformation brought about by these technologies is akin to a revolution in health care.
Latest:
FDA Sheds Light on New Drug Approvals in Breast CancerThe FDA is modernizing its approach to drug development and optimization.
Latest:
Advise Patients to Use Caution When Purchasing Nootropic Agents OnlineAlthough each of the product samples of phenibut contained the actual active ingredient, the exact amount of the active ingredient was inaccurate and, in one sample, found to be at a higher dose.
Latest:
Illegal Online Pharmacies Are Putting Patients at RiskThe growing volume of drugs sold through illegal online pharmacies are estimated to generate 10 times higher adverse event rates than drugs sold through legal pharmacies.
Latest:
Navigating the Great Medicare Migration: How Pharmacists Can Build Stronger Patient Relationships During the Annual Enrollment PeriodThe future of health care is one where pharmacists play a pivotal role, and the Annual Enrollment Period is the perfect opportunity to prove it.
Latest:
St. John’s Wort Could Show Benefit in Major Depressive DisorderPatients with MDD may also seek complementary or alternative therapies in the form of dietary supplements which might be perceived by patients to be natural and safer than medicinal agents.
Latest:
Is the 340B Hospitals Battle at the Supreme Court Over?Decision on payment reductions looks fleeting as ruling also provides HHS with instructions on cost-cutting goals.
Latest:
Evaluation of a Chemotherapy Advanced Preparation Pilot Program to Improve Throughput in an Oncology Infusion ClinicPharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.
Latest:
Immune Checkpoint Inhibitors Change Treatment Landscape for Metastatic Cervical CancerApproval of a novel antibody-drug conjugate ushers in new second-line option.
Latest:
Novel Treatments Could Turn the Tide for Alzheimer DiseaseAnti-amyloid antibody administration decreased plaque volume in clinical trials of patients with early AD, indicating that passive immunotherapies could be a promising treatment for the disease.
Latest:
Advancement in Stem Cell Transplantation: Improving Outcomes for Patients With Blood CancerAdvances, challenges, and promising innovations emerge.
Latest:
5 Quick Tips to Create a Transformative Advanced Pharmacy Practice Experiences RotationWhat many preceptors may not realize is that in addition to learning about practice settings, all graduates of pharmacy schools in the United States must also be able to demonstrate leadership, innovation, and entrepreneurship.
Latest:
Glucophage Will Activate the Same Pathway as Sprint Exercise to Reduce AppetiteThe oral medication activates an “anti-hunger” molecule which may prevent people from overeating.
Latest:
The Pharmacist’s Role: Opioid-related Risks With a Psychiatric DrugPharmacists dispensing Lybalvi should understand that potentially life-threatening consequences can occur if opioids are taken concurrently.
Latest:
Navigating Pediatric Atopic Dermatitis: Insights Into Treatment, Challenges, and Care ConsiderationsAtopic dermatitis significantly impacts quality of life, and requires personalized management through trigger identification, skin barrier maintenance, and a range of topical, oral, and biologic therapies to reduce symptoms and prevent flare-ups.
Latest:
The Role of Erenumab (Aimovig) in Treating Episodic, Chronic MigrainesErenumab (Aimovig) was the first anti-CGRP agent approved by the FDA for migraine prophylaxis.
Latest:
Interdisciplinary Approaches to Breast Cancer Care and ADC Treatment Barriers Due to Social Determinants of HealthPanelists discuss how optimizing antibody-drug conjugate (ADC) therapy in patients with metastatic breast cancer (mBC) requires interdisciplinary care, including oncologists, pharmacists, and nurses. Adherence barriers such as cost, access, and insurance are addressed via financial and social support.
Latest:
Bispecific T-Cell–Engaging Antibodies in B-Cell Lymphoma: Efficacy, Safety, and Practical ConsiderationsThis article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.
Latest:
Breaking Silos: How Health Systems and Manufacturers Can Drive Progress TogetherVanderbilt Specialty Pharmacy and Takeda Oncology are reaching across silos and entering an innovative partnership to improve patient care across the entire medication journey.
Latest:
Find New Career Paths and Opportunities for AdvancementMy own experience has illustrated how embracing change can lead to growth.
Latest:
Pharmacists Are Over-Looked Travel SpecialistsAs the summer months approach, pharmacists can offer many services to ensure patients remain safe and healthy during their travels.
Latest:
USC ALL Induction Regimen Combined With Newer TKIs Is Safe, Effective for Patients With Ph+ DiseaseAchieving MRD flow cytometry negativity is crucial in monitoring and predicting survival outcomes.
Latest:
What’s Next in Health Care: How Pharmacies Can Help Serve Their Communities BetterKey trends such as consolidation create an opportunity for independent pharmacies with a community-based approach.
Latest:
HER2-Targeted Treatments for NSCLC: Introducing ZongertinibCurrently, standard first-line chemotherapy with or without immunotherapy for patients with non-small-cell lung cancer (NSCLC) with HER2 mutations has limited efficacy.
Latest:
New Drug Overview: Aducanumab-Avwa (Aduhelm) for Alzheimer DiseaseAducanumab-avwa is a monoclonal antibody that is the first treatment of its class designed to target the amyloid β protein, a biomarker of Alzheimer disease and other dementias.
Latest:
Industry Trend Report: Consumer Comfort With Pharmacy-Provided Vaccinations and Services GrowsPharmacies can reach patients who are not receiving vaccines from a pharmacy but are willing to receive them.
Latest:
Personalized Treatments Advance Survival Outcomes for Patients With Lung CancerPrevention methods, including smoking cessation and public education, remain critical in combating the United States’ third most common cancer type.
